Although the difference in median survival of CRM positive patients was worse, at 17.4 months compared to 32.8 months for CRM negative tumours (figure 7 ), this did not reach statistical significance ( p = 0.195).
← all excerpts
The impact of operative approach on outcome of surgery for gastro-oesophageal tumours.
1
0.1950
0.1950